| 摘要 |
A conjugate of a toxin and a cytokine, and a fusion protein comprising a bispecific antibody that has a first specificity for a cell marker specific to a malignant cell and a second specificity for a region of IL-15.alpha., each optionally further comprising a radionuclide, are useful therapeutic reagents for treating leukemias and lymphomas.
|
